Skip to Main Content

CAR-T immunotherapy has proved a powerful treatment option for patients with certain advanced blood cancers — but it can be very dangerous as well, causing severe and sometimes deadly inflammation in the brain.

Now, researchers are a step closer to figuring out why — and to identifying those patients most likely to suffer severe reactions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!